Other
Antibiotic Therapy
0
Pipeline Programs↗
11
Active Trials↗
1
Companies Involved↗
Antibiotic Therapy is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
36
clinical trials
Completed16 · 44%
Recruiting10 · 28%
Unknown status6 · 17%
Withdrawn2 · 6%
Active, not recruiting1 · 3%
Terminated1 · 3%
Clinical Trials
Trial Activity
36 trials
Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection
Recruiting·—·N/A·NCT07030673·256 enrolled
Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial
Recruiting·—·N/A·NCT04048304·236 enrolled
Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days
Completed·—·Phase 2/3·NCT01203046·56 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)